Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in China.
Li L, Chen Y, Chen T, Xu Y, Zhu P, Shi J, Zhai W, Zhao Y, Xu Y, Lai X, Yu J, Liu L, Song X, Yang T, Lu Y, Yang K, Feng Y, Ni X, Lan J, Qiu X, Zhang Y, Jiang S, Huang H, Jiang E, Zhang X, Luo Y. Li L, et al. Among authors: chen t, chen y. Bone Marrow Transplant. 2024 Nov 8. doi: 10.1038/s41409-024-02454-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39516707
Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia.
Feng Y, Chen T, Zhang Y, Yao H, Wang P, Wang L, Cassady K, Zou Z, Liu Y, Zhao L, Gao L, Zhang X, Kong P. Feng Y, et al. Among authors: chen t. Front Immunol. 2023 Jun 22;14:1182251. doi: 10.3389/fimmu.2023.1182251. eCollection 2023. Front Immunol. 2023. PMID: 37435080 Free PMC article.
Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
Zhang C, Kong PY, Li S, Chen T, Ni X, Li Y, Wang M, Liu Y, Gao L, Gao L, Peng XG, Sun AH, Wang P, Yang Z, Zhang X, Qian C. Zhang C, et al. Among authors: chen t. J Immunother. 2018 Jul/Aug;41(6):306-311. doi: 10.1097/CJI.0000000000000233. J Immunother. 2018. PMID: 29864079 Review.
Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease: A Single-Center, Prospective, Single-Arm, Open-Label Study.
Chen T, Li J, Wei X, Yao H, Zhu L, Liu J, Liu Y, Wang P, Feng Y, Gao S, Liu H, Wang L, Zhao L, Gao L, Zhang C, Gao L, Zhang X, Kong P. Chen T, et al. Acta Haematol. 2024;147(5):499-510. doi: 10.1159/000536174. Epub 2024 Feb 16. Acta Haematol. 2024. PMID: 38232716 Clinical Trial.
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.
Huang R, Chen T, Wang S, Wang J, Su Y, Liu J, Zhang Y, Ma X, Wen Q, Kong P, Zhang C, Gao L, Zhong JF, Gao L, Zhang X. Huang R, et al. Among authors: chen t. JAMA Oncol. 2024 Feb 1;10(2):220-226. doi: 10.1001/jamaoncol.2023.5757. JAMA Oncol. 2024. PMID: 38153755 Free PMC article. Clinical Trial.
32,679 results
You have reached the last available page of results. Please see the User Guide for more information.